Nathaniel David

Nathaniel David
Born
San Francisco, California, U.S.
NationalityAmerican
Alma materHarvard University, University of California, Berkeley
Known forKythera Biopharmaceuticals, Kybella, Jupiter Bioventures
AwardsMIT Technology Review Young Innovators Under 35
Scientific career
FieldsBiotechnology
InstitutionsKythera Biopharmaceuticals, Unity Biotechnology, Jupiter Bioventures

Nathaniel David is an American scientist and biotechnology entrepreneur who has co-founded several life sciences companies that together have raised more than $1.5 billion in financing and contributed to the development of multiple FDA-approved medicines, including alogliptin, trelagliptin, Zemiglo (Zemdi), Zemdri, and Kybella.